Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.
Conghua XieNing LiYu TangXin WangYuan TangShu-Lian WangYong-Wen SongYue-Ping LiuYe-Xiong LiJing JinPublished in: Journal of surgical oncology (2019)
Hypofractionated stereotactic radiotherapy provides favorable outcomes with acceptable toxicities in CRC oligometastases. BED ≥ 100 Gy is associated with better outcomes.